Baldé A, Lang S, Wagner A, Ferrières J, Montaye M, Tattevin P, et al. Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status. PLoS One. 1 janv 2019;14(1):e0210253. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/30650119
Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, et al. Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals. Stat Med. 15 juin 2019;38(13):2428‑46. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/30883859
Costagliola D, Potard V, Lang S, Abgrall S, Duvivier C, Fischer H, et al. Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case-Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4). J Acquir Immune Defic Syndr. 1 févr 2019;80(2):214‑23. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/30422911
Grabar S, Hleyhel M, Belot A, Bouvier A-M, Tattevin P, Pacanowski J, et al. Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4. HIV Med. 1 mars 2019;20(3):222‑9. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/30693646
Gras L, May M, Ryder LP, Trickey A, Helleberg M, Obel N, et al. Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 1 mars 2019;80(3):292‑300. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/30531492
Lodi S, Phillips A, Lundgren J, Logan R, Sharma S, Cole SR, et al. Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples. Am J Epidemiol. 1 août 2019;188(8):1569‑77. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/31063192
Potard V, Canestri A, Gallien S, Costagliola D, French Hospital Database on HIV. Use of darunavir in HIV-1-infected individuals in routine clinical practice from 2012 to 2016 in France. J Antimicrob Chemother. 1 nov 2019;74(11):3305‑14. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/31384941
Tourret J, Guiguet M, Lassalle M, Grabar S, Lièvre L, Isnard-Bagnis C, et al. Access to the waiting list and to kidney transplantation for people living with HIV: A national registry study. Am J Transplant. 1 déc 2019;19(12):3345‑55. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/31206243
Trickey A, van Sighem A, Stover J, Abgrall S, Grabar S, Bonnet F, et al. Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings. AIDS. 15 déc 2019;33 Suppl 3(Suppl 3):S271‑81. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/31800404
Vourli G, Pharris A, Cazein F, Costagliola D, Dabis F, Del Amo J, et al. Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population? AIDS. 27 janv 2019;33(1):133‑43. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/30289806
